黄芩苷通过Nrf2/xCT/GPX4轴诱导骨肉瘤铁死亡
该研究在MG63和143B骨肉瘤细胞及异种移植小鼠模型中,探讨黄芩苷的抗骨肉瘤作用及铁死亡机制。黄芩苷可抑制肿瘤生长,促进铁积累、ROS形成和MDA产生,降低GSH/GSSG比值,诱导铁死亡;机制上黄芩苷与Nrf2结合并促进其泛素降解,下调GPX4和xCT,激活Nrf2/xCT/GPX4依赖的铁死亡轴。
要点
- 黄芩苷在体外和体内均抑制骨肉瘤生长。
- 黄芩苷通过促进铁积累和脂质过氧化诱导骨肉瘤细胞铁死亡。
- 黄芩苷靶向Nrf2并下调xCT/GPX4轴。
核心结论
- 黄芩苷通过新型Nrf2/xCT/GPX4依赖的铁死亡调控轴发挥抗骨肉瘤活性。
研究设计与样本
- 体外采用MG63和143B骨肉瘤细胞,体内采用异种移植小鼠模型研究黄芩苷的抗骨肉瘤作用及铁死亡机制。
主要发现
- 黄芩苷在体外和体内均显著抑制肿瘤细胞生长。
- 黄芩苷促进铁积累、ROS形成和MDA产生,并抑制GSH/GSSG比值,诱导骨肉瘤铁死亡。
- 铁死亡抑制剂ferrostatin-1(Fer-1)可逆转黄芩苷的抑制效应,表明铁死亡参与其抗骨肉瘤活性。
- 黄芩苷与Nrf2物理结合并通过诱导泛素降解影响其稳定性,抑制下游GPX4和xCT表达,促进铁死亡。
临床怎么用
- 该研究提示黄芩苷可能作为骨肉瘤治疗的候选药物,其抗肿瘤作用与诱导铁死亡相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Osteosarcomas (OS) is a kind of malignant bone tumor which occurs primarily in children and adolescents, and the clinical therapeutics remain disappointing. As a new programmed cell death, ferroptosis is characterized by iron dependent and intracellular oxidative accumulation, which provides a potential alternative intervene for the OS treatment. Baicalin, a major bioactive flavone derived from traditional Chinese medicine Scutellaria baicalensis, has been proved to have anti-tumor properties in OS. Whether ferroptosis participated in the baicalin mediated anti-OS activity is an interesting project. PURPOSE: To explore the pro-ferroptosis effect and mechanisms of baicalin in OS. METHODS/STUDY DESIGN: Pro-ferroptosis effect of baicalin on cell death, cell proliferation, iron accumulation, lipid peroxidation production was determined in MG63 and 143B cells. The levels of glutathione (GSH), oxidized (GSSG) glutathione and malondialdehyde (MDA) were determined by enzyme linked immunosorbent assay (ELISA). The expression levels of nuclear factor erythroid 2-related factor 2 (Nrf2), Glutathione peroxidase 4 (GPX4) and xCT were detected by western blot in baicalin-mediated ferroptosis regulation. In vivo, a xenograft mice model was adopted to explore the anticancer effect of baicalin. RESULTS: In the present study, it was found that baicalin significantly suppress tumor cell growth in vitro and in vivo. By promoting the Fe accumulation, ROS formation, MDA production and suppressing the ratio of GSH/GSSG, baicalin was found to trigger ferroptosis in OS and ferroptosis inhibitor ferrostatin-1 (Fer-1) successfully reversed these suppressive effects, indicating that ferroptosis participated in the baicalin mediated anti-OS activity. Mechanistically, baicalin physically interacted with Nrf2, a critical regulator of ferroptosis, and influenced its stability via inducing ubiquitin degradation, which suppressed the Nrf2 downstream targets GPX4 and xCT expression, and led to stimulating ferroptosis. CONCLUSIONS: Our findings for the first time indicated that baicalin exerted anti-OS activity through a novel Nrf2/xCT/GPX4-dependent ferroptosis regulatory axis, which hopefully provides a promising candidate for OS treatment.
引用
- Wen RJ, Dong X, Zhuang HW, et al. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis. Phytomedicine. 2023. PMID: 37209607. doi:10.1016/j.phymed.2023.154881
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。